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Abstract: 
Brown seaweeds are evolutionarily and chemically different from terrestrial plants. They 
contain many potential high value feedstocks, e.g. carbohydrate polymers (alginates, 
fucans), aliphatics (sterols, halocarbons), aromatics (polyphenols) and pigments.  In 
recent years, the bioactive of marine compounds are being increasingly recognised in 
antioxidant, anticancer, anti-inflammatory, anti-tuberculosis, anti-obesity, and anti-
angiogenic therapies. For example, fucosterol was previously shown to be the dominant 
sterol present in Ascophyllum nodosum [1], and one of its breakdown products, 
saringosterol, has shown some tentative evidence for anti-tuberculosis activity [2]. 
Phlorotannins (polyphenols) have shown some radical scavenging activity [3], which is 
of interest in reperfusion injuries (e.g. ischemic heart disease). To unlock their full 
commercial potential, better separation methods are needed to isolate compounds that 
translate to industrial scale up.  This project specifically investigates the potential 
extraction of high value compounds from Ascophyllum nodosum and their potential 
application in bone therapeutic. The aims of this work include: (1) to optimise suitable 
“green” methods for the extraction and purification of high value products, e.g. Fucoidan 
from Ascophyllum nodosum, (2) to screen their bioactivity and (3) test the extracts which 
show activity on cell cultures so their effects can be monitored. Results to date have 
shown methanol has been used to effectively extract fucoxanthin from Ascophyllum 
nodosum. Other results have indicated that oleic and linoleic acid, respectively, are the 
two most abundant fatty acids found in Ascophyllum nodosum. 
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